ALNY Earnings Alnylam Pharmaceuticals
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| FY 2025 | 2025-12-31 | 2.33 | 2026-02-12 | 10-K |
| FY 2025 | 2025-09-30 | 1.51 | 2026-02-12 | 10-K |
| FY 2025 | 2025-06-30 | -0.70 | 2026-02-12 | 10-K |
| FY 2025 | 2025-03-31 | -0.14 | 2026-02-12 | 10-K |
| FY 2025 | 2024-12-31 | -2.18 | 2026-02-12 | 10-K |
| Q3 2025 | 2024-09-30 | -1.53 | 2025-10-30 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.66 | 2025-07-31 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.52 | 2025-05-01 | 10-Q |
| FY 2025 | 2023-12-31 | -3.52 | 2026-02-12 | 10-K |
| Q3 2024 | 2023-09-30 | -2.43 | 2024-10-31 | 10-Q |
| Q2 2024 | 2023-06-30 | -3.62 | 2024-08-01 | 10-Q |
| Q1 2024 | 2023-03-31 | -1.40 | 2024-05-02 | 10-Q |
| FY 2024 | 2022-12-31 | -9.30 | 2025-02-13 | 10-K |
| Q3 2023 | 2022-09-30 | -7.62 | 2023-11-02 | 10-Q |
| Q2 2023 | 2022-06-30 | -4.29 | 2023-08-03 | 10-Q |
| Q1 2023 | 2022-03-31 | -2.00 | 2023-05-04 | 10-Q |
| FY 2023 | 2021-12-31 | -7.20 | 2024-02-15 | 10-K |
| Q3 2022 | 2021-09-30 | -5.04 | 2022-10-27 | 10-Q |
| Q2 2022 | 2021-06-30 | -3.32 | 2022-07-28 | 10-Q |
| Q1 2022 | 2021-03-31 | -1.71 | 2022-04-28 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.